Vertex Pharmaceuticals made headlines with a 14% share price jump, despite an overall market dip, thanks to clinical wins and ...

Cantor Fitzgerald assumed coverage of Vertex Pharmaceuticals (VRTX) with an Overweight rating and $535 price target Stay Ahead of the Market: ...

Vertex Pharmaceuticals’ short interest has dropped by 22.32%, now sitting at 1.74% of its float—Wall Street seems less pessimistic. Short interest reflects how many shares are being bet against and ...

Once I decided I wanted NotebookLM to help me with the topic, I went in search of string theory content (there's a lot more ...

Manchester City players are reportedly "worried" about Phil Foden after seeing his dramatic drop in form, with claims the 24-year-old has lost weight. Manchester United have changed Patrick Dorgu ...

It was of moderate difficulty level. All the assertion-reasoning and case study-based questions were according to the CBSE sample paper. The questions covered various domains of learning like ...

GEORGETOWN, S.C. (WBTW) — The site of the former International Paper mill in Georgetown that closed last year is soon set to turn into a biomass plant, state Sen. Stephen Goldfinch of Murrells ...

A recent executive order directs the federal government to stop issuing paper checks in favor of direct deposit, prepaid cards, or other digital payment options. The sentiment isn’t new ...

CBSE Board 2025 Exam Analysis: The Central Board of Secondary Education (CBSE) on March 26, held the Accountancy paper for the commerce stream students. The Accountancy Class 12 question paper was ...

Vertex Pharmaceuticals (VRTX) announced several updates on the company’s type 1 diabetes portfolio. Vertex has completed enrollment and dosing in Parts A and B of the Phase 1/2 VX-264 study and ...

VX-264 Update Vertex has completed enrollment and dosing in Parts A and B of thePhase 1/2 VX-264 (cells + device) study and the planned analysis at Day 90 for Part B. In Part B of the study ...

In the latest trading session, Vertex Pharmaceuticals (VRTX) closed at $502.55, marking a +0.45% move from the previous day. The stock's change was more than the S&P 500's daily loss of 0.33%.